MontVue Capital Management’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,089	Closed	-$249K	–	61
2024 Q3	$249K	Hold	2,089	–	–	0.19%	49
2024 Q2	$298K	Buy	2,089 +479	+30%	+$68.4K	0.24%	49
2024 Q1	$207K	Buy	+1,610	New	+$207K	0.18%	45